Effects of simvastatin on the mevalonate pathway and cell wall integrity of Staphylococcus aureus

Area of Science:

• Microbiology
• Biochemistry
• Pharmacology

Background:

• Staphylococcus aureus is a significant human pathogen.
• The mevalonate pathway is crucial for bacterial survival.
• Statins, like simvastatin, are primarily known for cholesterol reduction.

Purpose of the Study:

• To explore simvastatin's potential as an antimicrobial agent.
• To investigate simvastatin's impact on the mevalonate pathway in S. aureus.
• To determine simvastatin's effect on the S. aureus cell wall.

Main Methods:

• Exposing S. aureus to simvastatin with and without exogenous mevalonate.
• Performing gene expression analysis for mevalonate pathway, peptidoglycan synthesis, and cell wall stress genes.
• Utilizing transmission electron microscopy to observe morphological changes.

Main Results:

• Exogenous mevalonate partially or fully reversed simvastatin-induced inhibition.
• Simvastatin treatment led to increased expression of the vraX gene and decreased expression of the mvaA gene.
• Observed morphological alterations in S. aureus treated with simvastatin.

Conclusions:

• Simvastatin exhibits antimicrobial activity against S. aureus.
• The antimicrobial effect is linked to alterations in the bacterial cell wall.
• These cell wall changes are associated with the mevalonate pathway.